395869000: Rosiglitazone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\...

\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Rosiglitazone (substance)

\Peroxisome proliferator-activated gamma receptor agonist\Thiazolidinedione (substance)\Rosiglitazone (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Rosiglitazone (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Rosiglitazone (substance)

\Organic compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Rosiglitazone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1469809014 Rosiglitazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1489507011 Rosiglitazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

838851000172110 rosiglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Rosiglitazone (substance)	Is a	Thiazolidinedione (substance)	true	Inferred relationship	Some
Rosiglitazone (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Peroxisome proliferator-activated gamma receptor agonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing rosiglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	1
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Rosiglitazone maleate 2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Rosiglitazone maleate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Rosiglitazone maleate	Is a	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing metformin and rosiglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing glimepiride and rosiglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	1
Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	1
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 1 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone (substance)	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone (substance)	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone (substance)	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone (substance)	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 1 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rosiglitazone (substance)	Inferred relationship	Some	1
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone (substance)	Inferred relationship	Some	1
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing rosiglitazone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	1
Product containing metformin and rosiglitazone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Glimepiride- and rosiglitazone-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Rosiglitazone maleate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Rosiglitazone (substance)	Inferred relationship	Some
Product containing only glimepiride and rosiglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing only metformin and rosiglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing only rosiglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	1
Glimepiride and rosiglitazone only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Rosiglitazone only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	1
Metformin and rosiglitazone only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rosiglitazone (substance)	Inferred relationship	Some	2

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1469809014	Rosiglitazone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489507011	Rosiglitazone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
838851000172110	rosiglitazone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module